NextBillion - An Initiative of the William Davidson Institute at the University of Michigan

Friday, March 4, 2005

Glaxo India is planning to enter into an alliance with major government and private research centres in the country for developing its vaccines, especially in areas related to clinical development of its products. Kal Sundaram, the company?s managing director, admitted that the company was open for alliances and was, in fact, actively seeking these, in order to develop and launch vaccines for the Indian and South Asian market.
Full article available here.